Session aimed at healthcare personnel responsible for patients infected with or at risk of HIV and/or other infectious diseases.
Do you want to know the next activities on HIV?
Sign up to our newsletter list to be updated on upcoming activities.
Registration closed
Free
Attendees will learn about new treatments for HIV, such as Islatravir and Lenacapavir, and discuss studies on cardiovascular risk in people with HIV. The session will also analyze multi-drug resistant bacterial infections, available therapeutic options, and protocols for treating mycobacterial infections and emerging viral diseases like dengue and West Nile virus.
Head of HIV Section
Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
President of Fundació Lluita contra les Infeccions and Director of IrsiCaixa
Fundació Lluita contra les Infeccions, IrsiCaixa AIDS Research Institute and Catalan Health Institute, Badalona, Spain.
Director of Primary and Community Care
Metropolitana Nord